𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: Therapeutic perspective

✍ Scribed by P. Mazza; S. Tura; M. Bocchia; P. L. Zinzani; F. Gherlinzoni; F. Mandelli; M. P. Anselmo; G. Papa; M. Antimi; P. G. Gobbi; A. Porcellini; V. Rizzoli; L. Resegotti; A. Levis; L. Deriu; A. Chierichini; F. Ciccone; R. Fanin; G. Castoldi; G. L. Scapoli; V. Liso; T. Chisesi; L. Rancan; B. Amurri


Book ID
114791368
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
287 KB
Volume
45
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Interferon alfa-2b and chlorambucil in t
✍ Teodoro Chisesi; Giovanni Capnist; Michele Vespignani; Gianluigi Cetto πŸ“‚ Article πŸ“… 1987 πŸ› Springer US 🌐 English βš– 348 KB

Twenty-two patients with non-Hodgkin's lymphoma (NHL) were treated with a combined regimen of interferon alfa-2b (Intron A; Schering-Plough) and chlorambucil to evaluate the response and efficacy in pre-treated or relapsed patients. Ten patients were classified as having follicular lymphoma and 12 d

Combination trial of subcutaneous recomb
✍ Ozer, Howard ;Anderson, James R. ;Peterson, Bruce A. ;Budman, Daniel R. ;Cooper, πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 750 KB

## Abstract The follicular non‐Hodgkin's lymphomas (NHL) have been among those tumors demonstrated to show frequent responses to alpha interferon in phase I and II clinical trials. In addition, there are data suggesting that alpha interferon demonstrates synergistic antitumor activity with alkylati